Back to search

Netherlands· NL-6c1cc2b41566

Detrusitol SR 2 mg, capsules met verlengde afgifte, hard

A tolterodine product containing tolterodinetartraat, registered in Netherlands by Viatris Healthcare Limited. The same ATC class is registered in 16 of our 19 countries.

ATC G04BD07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDetrusitol SR 2 mg, capsules met verl…ATCG04BD07REGISTER NO.NL-6c1cc2b41566PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Tolterodine is registered in 16 of 19 countries.

Countries holding a registration under ATC G04BD07 (tolterodine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Tolterodine · ATC G04BD07

16 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tolterodine costs, country by country.

Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.70 in Italy to $1.95 in Switzerland — a ×2.8 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Tolterodine · price per daily dose (4 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.95
  • ES Spain$1.16
  • IT Italy$0.70
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TOLTERODINETARTRAAT
Manufacturer
Viatris Healthcare Limited
Country
Netherlands (NL)
ATC code
G04BD07
ATC class
Tolterodine
Defined daily dose
4 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    26669

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

324 interactions on record for tolterodine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tolterodine · interactions on record

324 records

  • 3 severe
  • 129 moderate
  • 33 minor
  • 152 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • ClotrimazoleA01AB18moderate

7 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tolterodine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tolterodine products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Detrusitol, Tolterodin Accord
  • Belgium · Detrusitol, Detrusitol Retard
  • Bulgaria · Толтеродин Акорд
  • Cyprus · Detrusitol, Tolterana
  • Germany · Detrusitol, Detrusitol Retard
  • Denmark · Detrusitol Retard, Tolterodin Rivopharm
  • Estonia · Uroflow
  • Spain · Detrusitol, Detrusitol Neo
  • Finland · Detrusitol, Detrusitol Sr
  • France · Detrusitol
  • United Kingdom (Northern Ireland) · Blerone Xl, Caristenol
  • Greece · Cinterol, Detrusitol
  • Ireland · Detrusitol, Detrusitol Sr
  • Iceland · Detrusitol Retard, Tolterodin Actavis
  • Italy · Detrusitol, Detrusitol Retard
  • Lithuania · Detrusitol, Detrusitol Sr
  • Luxembourg · Detrusitol, Detrusitol Retard
  • Latvia · Uroflow
  • Norway · Detrusitol Sr, Tolterodine Sandoz
  • Poland · Defur, Titlodine
  • Romania · Uroflow
  • Sweden · Detrusitol, Detrusitol Sr
  • Slovenia · Detrusitol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/24f833bb-330f-45e2-9349-7a582afcebaf
GET /v1/drugs/24f833bb-330f-45e2-9349-7a582afcebaf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule met gereguleerde afgifte, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h26669_smpc.pdf",
  "strength": null,
  "atc_label": "Tolterodine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg26669",
  "excipients": [
    "ETHYLCELLULOSE (E 462)",
    "GELATINE (E 441)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "INDIGOKARMIJN (E 132)",
    "MAÏSZETMEEL",
    "OLIEZUUR (E 570)",
    "PROPYLEENGLYCOL (E 1520)",
    "SACCHAROSE",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "SIMETICON",
    "SUIKERZETMEELBOLLETJES",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)",
    "TRIGLYCERIDEN MIDDELLANGE KETEN",
    "WITTE INKT"
  ],
  "substances": [
    "TOLTERODINETARTRAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h26669.pdf",
  "authorised_at": "2001/09/04",
  "procedure_number": "SE/H/0139/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "26669",
  "additional_monitoring": "N"
}

See everything about tolterodine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.